ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,329Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 127

$1.64M Total Retail Price of All Prescriptions

Rank: 2 out of 127

726 Patients Receiving at Least One Drug in Part D
9%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 726 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

7% of this provider’s 701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$176 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
TRAZODONE HCL 580 42 1 1
ZOLPIDEM TARTRATE 554 23 2 4
SEROQUEL XR 534 35 3 27
HYDROXYZINE PAMOATE 411 24 R 4 14
FLUOXETINE HCL 384 12 5 10
CITALOPRAM HBR 363 38 6 3
LAMOTRIGINE 335 17 7 5
RISPERIDONE 298 38 8 2
ABILIFY 283 27 9 7
CYMBALTA 280 22 10 8
BENZTROPINE MESYLATE 247 12 R 11 12
SERTRALINE HCL 212 23 12 6
BUSPIRONE HCL 207 0 13 20
QUETIAPINE FUMARATE 200 32 14 9
DIVALPROEX SODIUM ER 198 13 15 21
ESCITALOPRAM OXALATE 191 0 16 18
PAROXETINE HCL 186 44 17 22
LATUDA 184 0 18 51
OLANZAPINE 176 29 19 13
AMITRIPTYLINE HCL 154 0 R 20 40
HALOPERIDOL 150 0 21 34
INVEGA 144 0 22 46
LITHIUM CARBONATE 139 0 23 23
OXCARBAZEPINE 138 0 24 31
BUPROPION XL 138 0 24 19
VENLAFAXINE HCL ER 130 0 26 17
MIRTAZAPINE 122 0 27 11
CLOZAPINE 115 0 28 25
TOPIRAMATE 110 33 29 32
INVEGA SUSTENNA 103 0 30 38
PROPRANOLOL HCL 102 0 31 36
SAPHRIS 92 0 32 88
DIVALPROEX SODIUM 90 13 33 24
SEROQUEL 88 11 34 33
RISPERDAL CONSTA 87 0 35 41
STRATTERA 79 0 36 128
CHLORPROMAZINE HCL 76 0 37 42
ZIPRASIDONE HCL 76 0 37 30
TRIHEXYPHENIDYL HCL 63 0 R 39 29
BUPROPION HCL SR 61 0 40 26
LEXAPRO 60 0 41 53
HYDROXYZINE HCL 58 13 R 42 70
NAMENDA 53 11 43 15
GABAPENTIN 53 11 43 16
CARBAMAZEPINE 51 0 45 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.